Andrew N. Schiff, 10% Owner at Loxo Oncology, Inc. (LOXO), sold 1,400,000 shares at $179.43 ($251.2M) on 2018-07-10, disclosed to the SEC on 2018-07-12.
Open-market sale of $251.2M LOXO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2022-10-19 | $1.7M | — | Filing → |
| ACRS | SELL | 2022-10-11 | $237K | — | Filing → |
| ACRS | SELL | 2022-10-06 | $1.5M | — | Filing → |